Cart
sales@molnova.com
Bocidelpar
CAS No. 2095128-20-2
Bocidelpar( —— )
Catalog No. M28225 CAS No. 2095128-20-2
Bocidelpar is a modulator of PPARδ with an EC50 of 7.80 nM and improves mitochondrial biogenesis and function in Duchenne Muscular Dystrophy muscle cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 278 | In Stock |
|
| 5MG | 275 | In Stock |
|
| 10MG | 411 | In Stock |
|
| 25MG | 743 | In Stock |
|
| 50MG | 1088 | In Stock |
|
| 100MG | 1516 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBocidelpar
-
NoteResearch use only, not for human use.
-
Brief DescriptionBocidelpar is a modulator of PPARδ with an EC50 of 7.80 nM and improves mitochondrial biogenesis and function in Duchenne Muscular Dystrophy muscle cells.
-
DescriptionBocidelpar is a modulator of PPARδ with an EC50 of 7.80 nM and improves mitochondrial biogenesis and function in Duchenne Muscular Dystrophy muscle cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPotassium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2095128-20-2
-
Formula Weight460.49
-
Molecular FormulaC25H27F3N2O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (542.90 mM)
-
SMILESC[C@H](CCCOc1c(Cn2c(-c3ccc(C(F)(F)F)cc3)ncc2C)cccc1)CC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Su Z, et al. Novel cell-free high-throughput screening method for pharmacological tools targeting K+ channels. Proc Natl Acad Sci U S A. 2016;113(20):5748-5753.
molnova catalog
related products
-
Siramesine
Siramesine(Lu 28-179) is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of cancer cells and to exhibit a potent anticancer activity in vivo.
-
Suksdorfin
Suksdorfin has hypoglycemic effects, promotes adipocyte differentiation and enhances lipocalin production, activates peroxisome proliferator-activated receptor gamma (PPARγ), promotes insulin-dependent glucose uptake by adipocytes, and can be used to study obesity.
-
Saroglitazar
A novel PPAR agonist with predominant PPARα and moderate PPARγ activity with EC50 of 0.65 pM and 3 nM respectively.
